A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures

Trial Profile

A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures

Completed
Phase of Trial: Phase III

Latest Information Update: 15 Jun 2012

At a glance

  • Drugs Carisbamate (Primary)
  • Indications Partial epilepsies
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 07 Oct 2009 Actual patient number (563) added as reported by ClinicalTrials.gov.
    • 09 Dec 2008 Results were presented at AES 2008.
    • 16 Oct 2008 Actual end date (Oct 2007) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top